BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20526171)

  • 1. Atypical fibroxanthoma: a histological and immunohistochemical review of 171 cases.
    Beer TW; Drury P; Heenan PJ
    Am J Dermatopathol; 2010 Aug; 32(6):533-40. PubMed ID: 20526171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myxoid atypical fibroxanthoma: a previously undescribed variant.
    Patton A; Page R; Googe PB; King R
    J Cutan Pathol; 2009 Nov; 36(11):1177-84. PubMed ID: 19320792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma.
    Gleason BC; Calder KB; Cibull TL; Thomas AB; Billings SD; Morgan MB; Hiatt KM; Smoller BR
    J Cutan Pathol; 2009 May; 36(5):543-7. PubMed ID: 19476522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical staining of CD10 in atypical fibroxanthomas.
    Hultgren TL; DiMaio DJ
    J Cutan Pathol; 2007 May; 34(5):415-9. PubMed ID: 17448198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD117 immunoreactivity in atypical fibroxanthoma.
    Mathew RA; Schlauder SM; Calder KB; Morgan MB
    Am J Dermatopathol; 2008 Feb; 30(1):34-6. PubMed ID: 18212542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD117 is not a useful marker for diagnosing atypical fibroxanthoma.
    Beer TW; Haig D
    Am J Dermatopathol; 2009 Oct; 31(7):649-52. PubMed ID: 19652583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
    de Feraudy S; Mar N; McCalmont TH
    Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep "benign" fibrous histiocytoma: clinicopathologic analysis of 69 cases of a rare tumor indicating occasional metastatic potential.
    Gleason BC; Fletcher CD
    Am J Surg Pathol; 2008 Mar; 32(3):354-62. PubMed ID: 18300816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical fibrous histiocytoma and atypical fibroxanthoma: presentation of two cases.
    Kram A; Stańczyk J; Woyke S
    Pol J Pathol; 2003; 54(4):267-71. PubMed ID: 14998296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleomorphic dermal sarcoma: adverse histologic features predict aggressive behavior and allow distinction from atypical fibroxanthoma.
    Miller K; Goodlad JR; Brenn T
    Am J Surg Pathol; 2012 Sep; 36(9):1317-26. PubMed ID: 22510760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical fibroxanthoma with lymphomatoid reaction.
    Zheng R; Ma L; Bichakjian CK; Lowe L; Fullen DR
    J Cutan Pathol; 2011 Jan; 38(1):8-13. PubMed ID: 21039743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical distinction of cutaneous spindle cell carcinoma.
    Morgan MB; Purohit C; Anglin TR
    Am J Dermatopathol; 2008 Jun; 30(3):228-32. PubMed ID: 18496422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma.
    Sakamoto A; Oda Y; Itakura E; Oshiro Y; Nikaido O; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2001 Jun; 14(6):581-8. PubMed ID: 11406660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calponin and h-caldesmon expression in atypical fibroxanthoma and superficial leiomyosarcoma.
    Sakamoto A; Oda Y; Yamamoto H; Oshiro Y; Miyajima K; Itakura E; Tamiya S; Honda Y; Ishihara A; Iwamoto Y; Tsuneyoshi M
    Virchows Arch; 2002 Apr; 440(4):404-9. PubMed ID: 11956822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular neurothekeoma: detailed characterization in a series of 133 cases.
    Hornick JL; Fletcher CD
    Am J Surg Pathol; 2007 Mar; 31(3):329-40. PubMed ID: 17325474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myofibroblastic differentiation in atypical fibroxanthomas occurring on sun-exposed skin and in a burn scar: an ultrastructural and immunohistochemical study.
    Ito A; Yamada N; Yoshida Y; Morino S; Yamamoto O
    J Cutan Pathol; 2011 Aug; 38(8):670-6. PubMed ID: 21623865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular benign fibrous histiocytoma. Clinicopathologic analysis of 74 cases of a distinctive variant of cutaneous fibrous histiocytoma with frequent recurrence.
    Calonje E; Mentzel T; Fletcher CD
    Am J Surg Pathol; 1994 Jul; 18(7):668-76. PubMed ID: 8017561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspects of the differential diagnosis of clear-cell lesions of the skin in connection with the rare case of a clear-cell atypical fibroxanthoma.
    Kemmerling R; Dietze O; Müller S; Neureiter D
    Pathol Res Pract; 2009; 205(5):365-70. PubMed ID: 19155147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical fibroxanthoma with keloidal collagen.
    Fussell JN; Cooke ER; Florentino F; Sheehan DJ
    Am J Dermatopathol; 2010 Oct; 32(7):713-5. PubMed ID: 20700041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on plexiform fibrohistiocytic tumor and addition of 66 new cases from the Armed Forces Institute of Pathology, in honor of Franz M. Enzinger, MD.
    Moosavi C; Jha P; Fanburg-Smith JC
    Ann Diagn Pathol; 2007 Oct; 11(5):313-9. PubMed ID: 17870015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.